|
|
|
||
|
Pathological biochemistry (pathobiochemistry) deals with disorders of biochemical pathways and biochemical changes in human organism under pathological situations. The discipline aims to explain diseases at the molecular level. Some aspects of human physiological biochemistry (e.g. the biochemistry of digestion and absorption, synthesis and degradation of hemoglobin, and metabolism of lipoproteins), are also discussed in the course. The major goal of Pathobiochemistry in the Pharmacy program is to prepare students for future understanding molecular targetting of modern pharmacotherapeutics, taught in Pharmacology. This subject also contributes to the deepening of the medical education of the pharmacist.
Topics: Oxidative stres and antioxidant defense, biochemistry of inflammation, biochemistry of tumors, inherited errors of metabolism, physiological and pathological biochemistry of lipids, physiological and pathological biochemistry of saccharides, physiological and pathological biochemistry of nitrogen-containing compounds, pathological biochemistry of nervous systém, physiological and pathological biochemistry of purines and pyrimidines, biochemistry of porphyrines, pathological biochemistry of hormonal regulations
Last update: Boušová Iva, doc. PharmDr., Ph.D. (02.09.2025)
|
|
||
|
1) Passing the exam of General biochemistry shall be the condition for registration for the exam 2) Combined exam - written and oral part. Conditions are published in the Study materials on the faculty website 3) Registration for an examination shall be done electronically through Internet in the Student Information System (SIS). The student may not be registered for more terms of the same exam concurrently. 5) Teachers might ask additional questions from different areas of Pathological Biochemistry 6) All drawn and asked questions are equal with respect to validity of exam and exam results (exam mark) 7) The student may take the examination from the registered subject a maximum of three times, i.e. he/she has the right to two corrective dates; an extraordinary corrective date is not allowed. Last update: Boušová Iva, doc. PharmDr., Ph.D. (02.09.2025)
|
|
||
|
Obligatory:
Recommended:
Last update: Boušová Iva, doc. PharmDr., Ph.D. (20.01.2025)
|
|
||
|
Lectures Last update: Boušová Iva, doc. PharmDr., Ph.D. (02.09.2025)
|
|
||
|
Exam in Pathological Biochemistry shall be taken after completing the course of General Biochemistry. Last update: Boušová Iva, doc. PharmDr., Ph.D. (02.09.2025)
|
|
||
|
Introduction, mechanism of cell injury
Oxidation stress, radical diseases
Biochemistry of inflammation
Biochemistry of tumors
Hereditary metabolic disorders
Physiological and pathological biochemistry of lipids
Physiological and pathological biochemistry of carbohydrates
Physiological and pathological biochemistry of proteins and amino acids
Pathological biochemistry of nervous system
Nucleic acids, metabolism of purines and pyrimidines
Physiological and pathological biochemistry of porphyrines
Pathological biochemistry of hormones
Last update: Boušová Iva, doc. PharmDr., Ph.D. (02.09.2025)
|
|
||
|
The subject Pathological Biochemistry builds on the knowledge and skills acquired in the subjects: General Biochemistry, Human Morphology and Physiology, and Immunology. After completing the course, the student will be able to use the following terms (including their commonly used abbreviations) in the correct context towards biochemical characteristics and pathobiochemical changes in selected diseases: oxidative stress, reactive oxygen species, antioxidant, inflammation, mediator of inflammation, carcinogenesis, (pro)carcinogen, (proto)oncogene, antioncogene, lipoprotein, dyslipoproteinemia, lipidosis, steatosis and steatohepatitis, GLUT, SGLT, glucokinase, glycogenosis, mucopolysaccharidosis, hypoglycemia, hyperglycemia, insulin resistance, non-enzymatic glycation, glycated hemoglobin, macrophage scavenger receptors, atherosclerosis, abdominal obesity, adipokine, β-amyloid, α-synuclein, parkin, huntingtin, prion protein, ubiquitin, proteasome, hyperammonemia, phenylketonuria, newborn screening, inherited metabolic disorders, photosensitivity, icterus, hemoglobinopathy, hyperuricemia, endocrinopathy. Learning Outcomes: Students based on the knowledge and skills acquired: Ø define the importance of pathological biochemistry as a discipline; Ø orient themselves to the biochemical pathways associated with selected metabolic disorders; Ø explain how changes at the molecular or cellular level contribute to disease development and progression; Ø explain the role of genetic changes in biochemical pathways and their impact on pathological conditions; Ø describe biochemical changes in civilization diseases (e.g., diabetes mellitus, obesity, dyslipoproteinemia, or cancer); Ø explain how changes in enzyme (and/or transporter) activity affect metabolite levels in the body and demonstrate these changes in an example; Ø identify key biochemical markers used in laboratory diagnostics and monitoring of disease progression and treatment; Ø interpret the results of basic biochemical laboratory tests (e.g., liver function tests, blood glucose levels, blood lipid, and lipoprotein levels) and compare them to disease states; Ø describe the biochemical basis for rational drug therapy of disease.
Last update: Boušová Iva, doc. PharmDr., Ph.D. (02.09.2025)
|